Cancer vaccines can trigger an anti-cancer immune response, but responses in patients are limited by the requirement of a T-cell inflamed tumor. Oncolytic viruses (OV) infect and selectively replicate in tumor cells, thereby inducing immunogenic cell death (ICD), resulting in the release of tumor antigens and the (re-)activation and attraction of effector T cells. In this KWF-Alpe d'HuZes funded project, you will focus on developing a novel in situ cancer vaccination method wherein oncolytic viruses will be armed with multi-specific single domain antibodies to boost DC antigen uptake and cancer-specific T-cell responses.
Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page.
You will work in a team of young and enthusiastic researchers who have expertise in tumor immunology, immunotherapy, oncolytic viruses and cancer. Research is embedded within the research institutes Cancer Center Amsterdam (CCA) and Amsterdam Immunity and Infection Institute (AI&II).
In this PhD-project, you will generate and characterize multi-specific single domain antibodies (sdAb) to arm OV for subsequent evaluation in cutting edge preclinical and in vivo models.
Your main tasks and responsibilities are:
Watch this video with more information about joining Amsterdam UMC Research BV.
The Immunotherapy Lab of the Department of Medical Oncology in which you will be embedded (supervised by Dr. Roeland Lameris and Prof. Dr. Tanja de Gruijl), translates preclinical findings from the lab to the clinic in order to implement novel immunotherapies for cancer. Our research includes tumor-induced immune suppression, myeloid cells as therapeutic targets, characterization and immune potentiation of tumor-draining lymph nodes, sdAb-based bispecifics for tumor targeting as well as the profiling and immune monitoring of cancer, lymph nodes and blood by flow cytometry and (spatial) transcriptomics. We will collaborate with Prof. Victor van Beusechem for oncolytic virotherapy expertise and in vivo experiments will be performed in close collaboration with Prof. Derk Amsen (Sanquin, The Netherlands).
Amsterdam UMC Research BV supports non-profit scientific research. In doing so, we provide researchers with everything they need to excel. Our principal investigators (PIs) and project leaders offer support in the field of project management, finance and human resources. In medical scientific research projects, legal support is also provided.
Watch the video to find out more.
Note! Applications should include a CV, cover letter, and the contact information of at least two references. An assessment may be part of the selection procedure. The first interview will be conducted in-person or online, and will be followed by a second on-site presentation and interview.
During the publication period, applications will be handled continuously. If the vacancy is filled, it will be closed prematurely.
If you have any questions about this position, please feel free to contact dr. Roeland Lameris via r.lameris@amsterdamumc.nl.
For more information about the application procedure, please contact Rhiannon Sandfort, Recruitment advisor, via r.e.sandfort@amsterdamumc.nl.
A reference check, screening and hiring test may be part of the procedure. Read here whether that applies to you. If you join us, we ask you for a VOG (Certificate of Good Conduct).
Internal candidates will be given priority over external candidates in case of equal suitability.
Acquisition in response to this vacancy is not appreciated.